Skip to main content
Erschienen in: Acta Neuropathologica 5/2010

01.05.2010 | Original Paper

Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels

verfasst von: Paula Cunnea, Jill McMahon, Enda O’Connell, Kaveh Mashayekhi, Una Fitzgerald, Stephen McQuaid

Erschienen in: Acta Neuropathologica | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

The blood brain barrier (BBB) is formed by capillary endothelial cells with inter-endothelial cell tight junctions and other cells such as pericytes and astrocytes present. Previous studies have shown a role for tight junction abnormalities in BBB leakage in multiple sclerosis (MS) brain. This marks a key stage in the development of inflammatory demyelination in MS. The aim of this study was to identify aberrantly expressed genes involved in BBB changes in MS lesions. A focused endothelial cell biology microarray, capable of detecting changes in expression of 113 endothelial cell-specific genes, was employed to analyse endothelial cell mRNA extracted from post-mortem control white matter, MS normal appearing white matter (NAWM), chronic active or inactive lesions by laser capture microdissection. Microarray analysis found 52 genes out of 113 analysed, predominantly in the activation functional group, to be differentially expressed in lesions compared to control or NAWM (p < 0.01). The majority of the differentially expressed genes were validated by quantitative real time PCR. In addition, the protein expression profiles of ICAM2, MMP2, and VEGFR1 were examined by immunofluorescent staining of selected tissue blocks. ICAM-2 was expressed at a higher level in chronic inactive lesions than control or NAWM, corresponding with the increased mRNA measured by microarray and real time PCR. The data shown, presenting a number of differentially expressed genes in the microvascular compartment of MS lesions, may shed light on the molecular mechanisms that are involved in the breakdown of the BBB. This moves us a step closer to the identification of potential therapeutic targets for repair of the compromised BBB.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41–53CrossRefPubMed Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41–53CrossRefPubMed
2.
Zurück zum Zitat Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 106:1977–1982CrossRefPubMed Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 106:1977–1982CrossRefPubMed
3.
Zurück zum Zitat Argaw AT, Zhang Y, Snyder BJ et al (2006) IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 177:5574–5584PubMed Argaw AT, Zhang Y, Snyder BJ et al (2006) IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 177:5574–5584PubMed
4.
Zurück zum Zitat Avolio C, Ruggieri M, Giuliani F et al (2003) Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol 136:46–53CrossRefPubMed Avolio C, Ruggieri M, Giuliani F et al (2003) Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol 136:46–53CrossRefPubMed
5.
Zurück zum Zitat Ball HJ, McParland B, Driussi C, Hunt NH (2002) Isolating vessels from the mouse brain for gene expression analysis using laser capture microdissection. Brain Res Brain Res Protoc 9:206–213CrossRefPubMed Ball HJ, McParland B, Driussi C, Hunt NH (2002) Isolating vessels from the mouse brain for gene expression analysis using laser capture microdissection. Brain Res Brain Res Protoc 9:206–213CrossRefPubMed
6.
Zurück zum Zitat Ballabh P, Hu F, Kumarasiri M, Braun A, Nedergaard M (2005) Development of tight junction molecules in blood vessels of germinal matrix, cerebral cortex, and white matter. Pediatr Res 58:791–798CrossRefPubMed Ballabh P, Hu F, Kumarasiri M, Braun A, Nedergaard M (2005) Development of tight junction molecules in blood vessels of germinal matrix, cerebral cortex, and white matter. Pediatr Res 58:791–798CrossRefPubMed
7.
Zurück zum Zitat Bates DO, Harper SJ (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39:225–237CrossRefPubMed Bates DO, Harper SJ (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39:225–237CrossRefPubMed
8.
Zurück zum Zitat Benesova Y, Vasku A, Novotna H et al (2009) Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis. Mult Scler 15:316–322CrossRefPubMed Benesova Y, Vasku A, Novotna H et al (2009) Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis. Mult Scler 15:316–322CrossRefPubMed
9.
Zurück zum Zitat Bernard R, Kerman IA, Meng F et al (2009) Gene expression profiling of neurochemically defined regions of the human brain by in situ hybridization-guided laser capture microdissection. J Neurosci Methods 178:46–54CrossRefPubMed Bernard R, Kerman IA, Meng F et al (2009) Gene expression profiling of neurochemically defined regions of the human brain by in situ hybridization-guided laser capture microdissection. J Neurosci Methods 178:46–54CrossRefPubMed
10.
Zurück zum Zitat Bo L, Peterson JW, Mork S et al (1996) Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Exp Neurol 55:1060–1072PubMed Bo L, Peterson JW, Mork S et al (1996) Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Exp Neurol 55:1060–1072PubMed
11.
Zurück zum Zitat Candelario-Jalil E, Yang Y, Rosenberg GA (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158:983–994CrossRefPubMed Candelario-Jalil E, Yang Y, Rosenberg GA (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158:983–994CrossRefPubMed
12.
Zurück zum Zitat Claudio L, Kress Y, Norton WT, Brosnan CF (1989) Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am J Pathol 135:1157–1168PubMed Claudio L, Kress Y, Norton WT, Brosnan CF (1989) Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am J Pathol 135:1157–1168PubMed
13.
Zurück zum Zitat Comabella M, Romera C, Camina M et al (2006) TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis. J Neurol 253:701–706CrossRefPubMed Comabella M, Romera C, Camina M et al (2006) TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis. J Neurol 253:701–706CrossRefPubMed
14.
Zurück zum Zitat Coudry RA, Meireles SI, Stoyanova R et al (2007) Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. J Mol Diagn 9:70–79CrossRefPubMed Coudry RA, Meireles SI, Stoyanova R et al (2007) Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. J Mol Diagn 9:70–79CrossRefPubMed
15.
Zurück zum Zitat Domazet B, Maclennan GT, Lopez-Beltran A, Montironi R, Cheng L (2008) Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer. Int J Clin Exp Pathol 1:475–488PubMed Domazet B, Maclennan GT, Lopez-Beltran A, Montironi R, Cheng L (2008) Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer. Int J Clin Exp Pathol 1:475–488PubMed
16.
Zurück zum Zitat Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29:258–289CrossRefPubMed Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29:258–289CrossRefPubMed
17.
Zurück zum Zitat Emmert-Buck MR, Bonner RF, Smith PD et al (1996) Laser capture microdissection. Science 274:998–1001CrossRefPubMed Emmert-Buck MR, Bonner RF, Smith PD et al (1996) Laser capture microdissection. Science 274:998–1001CrossRefPubMed
18.
Zurück zum Zitat Fainardi E, Castellazzi M, Bellini T et al (2006) Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 12:294–301CrossRefPubMed Fainardi E, Castellazzi M, Bellini T et al (2006) Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 12:294–301CrossRefPubMed
19.
Zurück zum Zitat Gjerdrum LM, Abrahamsen HN, Villegas B et al (2004) The influence of immunohistochemistry on mRNA recovery from microdissected frozen and formalin-fixed, paraffin-embedded sections. Diagn Mol Pathol 13:224–233CrossRefPubMed Gjerdrum LM, Abrahamsen HN, Villegas B et al (2004) The influence of immunohistochemistry on mRNA recovery from microdissected frozen and formalin-fixed, paraffin-embedded sections. Diagn Mol Pathol 13:224–233CrossRefPubMed
20.
Zurück zum Zitat Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13:554–573PubMed Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13:554–573PubMed
21.
Zurück zum Zitat Harris LW, Wayland M, Lan M et al (2008) The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS ONE 3:e3964CrossRefPubMed Harris LW, Wayland M, Lan M et al (2008) The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS ONE 3:e3964CrossRefPubMed
22.
Zurück zum Zitat Kerman IA, Buck BJ, Evans SJ, Akil H, Watson SJ (2006) Combining laser capture microdissection with quantitative real-time PCR: effects of tissue manipulation on RNA quality and gene expression. J Neurosci Methods 153:71–85CrossRefPubMed Kerman IA, Buck BJ, Evans SJ, Akil H, Watson SJ (2006) Combining laser capture microdissection with quantitative real-time PCR: effects of tissue manipulation on RNA quality and gene expression. J Neurosci Methods 153:71–85CrossRefPubMed
23.
Zurück zum Zitat Kermode AG, Thompson AJ, Tofts P et al (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113(Pt 5):1477–1489CrossRefPubMed Kermode AG, Thompson AJ, Tofts P et al (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113(Pt 5):1477–1489CrossRefPubMed
24.
Zurück zum Zitat Kirk J, Plumb J, Mirakhur M, McQuaid S (2003) Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201:319–327CrossRefPubMed Kirk J, Plumb J, Mirakhur M, McQuaid S (2003) Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201:319–327CrossRefPubMed
25.
Zurück zum Zitat Kirk SL, Karlik SJ (2003) VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 21:353–363CrossRefPubMed Kirk SL, Karlik SJ (2003) VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 21:353–363CrossRefPubMed
26.
Zurück zum Zitat Kluger MS (2004) Vascular endothelial cell adhesion and signaling during leukocyte recruitment. Adv Dermatol 20:163–201PubMed Kluger MS (2004) Vascular endothelial cell adhesion and signaling during leukocyte recruitment. Adv Dermatol 20:163–201PubMed
27.
Zurück zum Zitat Koning N, Bo L, Hoek RM, Huitinga I (2007) Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 62:504–514CrossRefPubMed Koning N, Bo L, Hoek RM, Huitinga I (2007) Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 62:504–514CrossRefPubMed
28.
Zurück zum Zitat Krum JM, Mani N, Rosenstein JM (2008) Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 212:108–117CrossRefPubMed Krum JM, Mani N, Rosenstein JM (2008) Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 212:108–117CrossRefPubMed
29.
Zurück zum Zitat Leech S, Kirk J, Plumb J, McQuaid S (2007) Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 33:86–98CrossRefPubMed Leech S, Kirk J, Plumb J, McQuaid S (2007) Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 33:86–98CrossRefPubMed
30.
Zurück zum Zitat Leppert D, Ford J, Stabler G et al (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121(Pt 12):2327–2334CrossRefPubMed Leppert D, Ford J, Stabler G et al (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121(Pt 12):2327–2334CrossRefPubMed
31.
Zurück zum Zitat Lindberg RL, De Groot CJ, Montagne L et al (2001) The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743–1753CrossRefPubMed Lindberg RL, De Groot CJ, Montagne L et al (2001) The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743–1753CrossRefPubMed
32.
Zurück zum Zitat Lock C, Hermans G, Pedotti R et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500–508CrossRefPubMed Lock C, Hermans G, Pedotti R et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500–508CrossRefPubMed
33.
Zurück zum Zitat Macdonald JA, Murugesan N, Pachter JS (2008) Validation of immuno-laser capture microdissection coupled with quantitative RT-PCR to probe blood-brain barrier gene expression in situ. J Neurosci Methods 174:219–226CrossRefPubMed Macdonald JA, Murugesan N, Pachter JS (2008) Validation of immuno-laser capture microdissection coupled with quantitative RT-PCR to probe blood-brain barrier gene expression in situ. J Neurosci Methods 174:219–226CrossRefPubMed
34.
Zurück zum Zitat McQuaid S, Cunnea P, McMahon J, Fitzgerald U (2009) The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. Biochem Soc Trans 37:329–331CrossRefPubMed McQuaid S, Cunnea P, McMahon J, Fitzgerald U (2009) The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. Biochem Soc Trans 37:329–331CrossRefPubMed
35.
Zurück zum Zitat Medrano S, Steward O (2001) Differential mRNA localization in astroglial cells in culture. J Comp Neurol 430:56–71CrossRefPubMed Medrano S, Steward O (2001) Differential mRNA localization in astroglial cells in culture. J Comp Neurol 430:56–71CrossRefPubMed
36.
Zurück zum Zitat Minagar A, Alexander JS, Schwendimann RN et al (2008) Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial. Arch Neurol 65:199–204CrossRefPubMed Minagar A, Alexander JS, Schwendimann RN et al (2008) Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial. Arch Neurol 65:199–204CrossRefPubMed
37.
Zurück zum Zitat Mochizuki S, Okada Y (2007) ADAMs in cancer cell proliferation and progression. Cancer Sci 98:621–628CrossRefPubMed Mochizuki S, Okada Y (2007) ADAMs in cancer cell proliferation and progression. Cancer Sci 98:621–628CrossRefPubMed
38.
Zurück zum Zitat Mojsilovic-Petrovic J, Nesic M, Pen A, Zhang W, Stanimirovic D (2004) Development of rapid staining protocols for laser-capture microdissection of brain vessels from human and rat coupled to gene expression analyses. J Neurosci Methods 133:39–48CrossRefPubMed Mojsilovic-Petrovic J, Nesic M, Pen A, Zhang W, Stanimirovic D (2004) Development of rapid staining protocols for laser-capture microdissection of brain vessels from human and rat coupled to gene expression analyses. J Neurosci Methods 133:39–48CrossRefPubMed
39.
Zurück zum Zitat Muroski ME, Roycik MD, Newcomer RG et al (2008) Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol 9:34–46CrossRefPubMed Muroski ME, Roycik MD, Newcomer RG et al (2008) Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol 9:34–46CrossRefPubMed
40.
Zurück zum Zitat Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW (2003) cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 126:1048–1057CrossRefPubMed Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW (2003) cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 126:1048–1057CrossRefPubMed
41.
Zurück zum Zitat Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW (2004) Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin Neurol Neurosurg 106:223–229CrossRefPubMed Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW (2004) Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin Neurol Neurosurg 106:223–229CrossRefPubMed
42.
Zurück zum Zitat Padden M, Leech S, Craig B et al (2007) Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol 113:177–186CrossRefPubMed Padden M, Leech S, Craig B et al (2007) Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol 113:177–186CrossRefPubMed
43.
Zurück zum Zitat Plumb J, McQuaid S, Cross AK et al (2006) Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Mult Scler 12:375–385CrossRefPubMed Plumb J, McQuaid S, Cross AK et al (2006) Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Mult Scler 12:375–385CrossRefPubMed
44.
Zurück zum Zitat Plumb J, McQuaid S, Mirakhur M, Kirk J (2002) Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 12:154–169PubMedCrossRef Plumb J, McQuaid S, Mirakhur M, Kirk J (2002) Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 12:154–169PubMedCrossRef
45.
Zurück zum Zitat Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ (2002) Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 61:914–925PubMed Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ (2002) Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 61:914–925PubMed
46.
Zurück zum Zitat Roebuck KA, Finnegan A (1999) Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66:876–888PubMed Roebuck KA, Finnegan A (1999) Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66:876–888PubMed
47.
Zurück zum Zitat Roscoe WA, Welsh ME, Carter DE, Karlik SJ (2009) VEGF and angiogenesis in acute and chronic MOG ((35–55)) peptide induced EAE. J Neuroimmunol 209:6–15CrossRefPubMed Roscoe WA, Welsh ME, Carter DE, Karlik SJ (2009) VEGF and angiogenesis in acute and chronic MOG ((35–55)) peptide induced EAE. J Neuroimmunol 209:6–15CrossRefPubMed
48.
Zurück zum Zitat Scicchitano MS, Dalmas DA, Bertiaux MA et al (2006) Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. J Histochem Cytochem 54:1229–1237CrossRefPubMed Scicchitano MS, Dalmas DA, Bertiaux MA et al (2006) Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. J Histochem Cytochem 54:1229–1237CrossRefPubMed
49.
Zurück zum Zitat Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7–30CrossRefPubMed Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7–30CrossRefPubMed
50.
Zurück zum Zitat Soon D, Tozer DJ, Altmann DR, Tofts PS, Miller DH (2007) Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 13:884–894CrossRefPubMed Soon D, Tozer DJ, Altmann DR, Tofts PS, Miller DH (2007) Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 13:884–894CrossRefPubMed
51.
Zurück zum Zitat Whitney LW, Ludwin SK, McFarland HF, Biddison WE (2001) Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol 121:40–48CrossRefPubMed Whitney LW, Ludwin SK, McFarland HF, Biddison WE (2001) Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol 121:40–48CrossRefPubMed
52.
Zurück zum Zitat Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N (2008) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131:288–303CrossRefPubMed Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N (2008) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131:288–303CrossRefPubMed
Metadaten
Titel
Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels
verfasst von
Paula Cunnea
Jill McMahon
Enda O’Connell
Kaveh Mashayekhi
Una Fitzgerald
Stephen McQuaid
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 5/2010
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-009-0618-9

Weitere Artikel der Ausgabe 5/2010

Acta Neuropathologica 5/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.